These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3134741)

  • 1. Exchange of cyclooxygenase dependent metabolites between vessel wall and platelets in arterial thrombosis.
    Bourgain RH; Andries R; Decuyper K; Braquet P
    Thromb Res; 1988 May; 50(3):401-8. PubMed ID: 3134741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclooxygenase inhibition on platelet-vessel wall interaction.
    Bourgain RH; Andries R; Maes L
    Haemostasis; 1983; 13(2):102-8. PubMed ID: 6409710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of inhibition of endothelial cell cyclooxygenase on arterial thrombosis.
    Bourgain RH; Andries R; Braquet P; Deby C
    Prostaglandins; 1985 Dec; 30(6):915-23. PubMed ID: 3937181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH; Andries R; Decuyper K; De Clerck F
    J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of cyclooxygenase and prostacyclin-synthetase inhibitors on platelet-vessel wall interaction.
    Bourgain RH; Six F; Andries R
    Artery; 1980; 8(1):96-100. PubMed ID: 6775620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships between prostacyclin and thromboxane A2.
    Moncada S; Vane JR
    Ciba Found Symp; 1980; 78():165-83. PubMed ID: 6258879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tachyphylactic effect of arachidonic acid on in-vivo ADP induced arterial platelet thrombosis.
    Bourgain RH; Andries R; Deby C
    Thromb Res; 1985 Jul; 39(2):231-6. PubMed ID: 3927512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of the arachidonic acid--thromboxane pathway.
    Mitchell JR
    Br Med Bull; 1983 Jul; 39(3):289-95. PubMed ID: 6226333
    [No Abstract]   [Full Text] [Related]  

  • 13. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K
    Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of rat platelet activation by vessel wall-derived prostaglandin and platelet-derived thromboxane: effects of dietary fish oil on thromboxane-prostaglandin balance.
    Nieuwenhuys CM; Feijge MA; Offermans RF; Kester AD; Hornstra G; Heemskerk JW
    Atherosclerosis; 2001 Feb; 154(2):355-66. PubMed ID: 11166768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis.
    Badimon L; Vilahur G; Rocca B; Patrono C
    Cardiovasc Res; 2021 Jul; 117(9):2001-2015. PubMed ID: 33484117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S; Amezcua JL
    Haemostasis; 1979; 8(3-5):252-65. PubMed ID: 389758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole inhibits in vivo rat platelet aggregation by a release of prostacyclin-like factor.
    Pinto A; Sorrentino R; Sorrentino L
    Gen Pharmacol; 1990; 21(2):255-9. PubMed ID: 2110089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 20. The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.
    Emms H; Lewis GP
    Br J Pharmacol; 1986 Jan; 87(1):109-15. PubMed ID: 3082399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.